Targeted News Service

Goodwin Advises Lakefront Biotherapeutics on Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics
October 21, 2026

BOSTON, Massachusetts, Oct. 21 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises Lakefront Biotherapeutics on Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics

*

The Life Sciences team advised Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") on the sale of its early-stage cell therapy pipeline to Armed Cell Therapeutics BV, a Belgium-based biot . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form